Nobel Biocare

What Nobel Biocare does

Nobel Biocare Services AG is a Switzerland-domiciled medical device company that designs, manufactures, and commercializes premium dental implant systems, CAD/CAM-based individualized prosthetics, and digital dentistry workflow software for dental surgeons, periodontists, prosthodontists, and dental laboratories. Its core technology is built on osseointegration, the bone-implant bonding phenomenon discovered by Per-Ingvar Brånemark, with proprietary surface chemistries such as TiUltra, TiUnite, Xeal, and Mucointegration applied across multiple implant platforms including N1, NobelActive, NobelParallel, NobelReplace, NobelSpeedy, NobelPearl, and NobelZygoma. The company sells the All-on-4 treatment concept for full-arch rehabilitation, along with the DTX Studio Suite software, NobelProcera prosthetic manufacturing service, ICam photogrammetry, and X-Guide NXT surgical navigation.

Nobel Biocare makes money primarily through hardware sales of implants, abutments, crowns, bridges, surgical instruments, and regenerative biomaterials, complemented by recurring software licensing for DTX Studio and professional-services revenue from clinical education programs. Pricing is quote-based and reflects the premium positioning of the brand. The go-to-market combines an enterprise field-sales organization with regional subsidiaries across the Americas, EMEA, and Asia Pacific, supported by an e-commerce storefront for repeat and mid-market customers and distributor relationships in selected geographies.

The company has accumulated more than 4,500 peer-reviewed scientific publications and has rehabilitated over 20 million patients globally, providing substantial clinical-evidence depth. It was acquired by Envista Holdings Corporation (NYSE: ENV) in 2021 and now operates as a wholly-owned subsidiary under Envista's portfolio. Nobel Biocare maintains ISO 13485, ISO 14001, MDSAP, EU MDR, and UKCA certifications, and secured FDA 510(k) clearance for the NobelZygoma TiUltra implant system in August 2025.

Name

Nobel Biocare

Legal name

Nobel Biocare Services AG

Website

https://nobelbiocare.com

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Nobel Biocare Services AG designs and sells premium dental implant systems, CAD/CAM prosthetics, and digital dentistry workflow software to dental surgeons and laboratories worldwide, operating as a wholly-owned subsidiary of Envista Holdings Corporation (NYSE: ENV).

Ownership category

akta.pro rank

Product category

Dental Implants

NAICS

Dental Laboratories (339116), Dental Equipment and Supplies Manufacturing (339114), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843)

akta.pro primary industry

Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)

akta.pro secondary industries

Implant Prosthodontics (Implant-Supported Restorations) (HLABAFAC), 3D Printing/Additive Manufacturing for Dental Prosthetics (HLABAJAF), Removable Prosthodontics (Complete & Partial Dentures) (HLABAFAB), Digital Prosthodontics & CAD/CAM Restorations (Chairside/Clinic-Based) (HLABAFAH), Implant Prosthetics & Abutment Fabrication (HLABAJAC), Crown & Bridge (Fixed Prosthetics) Fabrication (HLABAJAA)

Keywords

• Dental implant systems
• CAD/CAM prosthetics
• Digital dentistry software
• Implant surface technology
• Surgical navigation systems

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices12 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Dental implant systems: Sale of dental implants including NobelReplace, NobelActive, NobelParallel, NobelSpeedy, NobelZygoma, and N1 systems. Products sold directly through sales representatives and e-commerce platform.
2. Prosthetic components: Abutments, crowns, bridges, and implant bars sold to dental laboratories and clinicians. Includes NobelProcera CAD/CAM prosthetic solutions.
3. Surgical instruments: Surgical tools and instruments including OsseoShaper, drilling units, and screwdrivers for implant placement procedures.
4. Digital solutions software: DTX Studio Suite software platform for digital treatment planning and workflow management.
5. Regenerative products: creos biomaterial products for bone and tissue regeneration.
6. Education and training services: Professional development courses, webinars, and certification programs for dental professionals.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Nobel Biocare manufactures dental implant systems and CAD/CAM-based individualized prosthetics, supplying dental professionals with complete solutions spanning diagnosis, surgical planning, implant placement, and final restoration. The company complements its physical implant portfolio with digital dentistry software (DTX Studio suite) and ancillary offerings such as regenerative products and continuing professional education.

Product overview

Nobel Biocare is a leading innovator of implant-based dental restorations, offering a comprehensive portfolio of dental implant systems, prosthetic solutions, and digital dentistry technologies. The product portfolio centers on multiple implant systems (N1™, NobelActive®, NobelParallel™, NobelReplace®, NobelSpeedy®, NobelPearl™ zirconia, NobelZygoma™ for severe atrophy), enhanced by proprietary surface technologies (TiUltra™, Xeal™). The ecosystem includes NobelProcera® custom prosthetics, the DTX Studio™ digital software suite, surgical navigation (X-Guide® NXT), photogrammetry (ICam), and the All-on-4® treatment concept. The company provides approximately 4,500 published scientific articles supporting its products and has rehabilitated over 20 million smiles globally.

Differentiator

Problem solved

Functional benefit

Brands

• NobelProcera: CAD/CAM prosthetic solutions including abutments, crowns, bridges, and implant bars for dental restorations
• DTX Studio
• All-on-4
• Procera
• creos

Products and services

• Nobel Biocare N1™ Implant System
• NobelActive® Implant System
• NobelParallel™ Implant System
• NobelReplace® Implant System
• NobelSpeedy® Implant System
• NobelPearl™ Implant System
• NobelZygoma™ Implant System
• All-on-4® Treatment Concept
• NobelProcera® Prosthetic Solutions
• DTX Studio™ Suite
• creos™ Regenerative Solutions
• X-Guide® Surgical Navigation System
• ICam™
• Brånemark System®
• Education & Training Programs

Quantifiable outcome

• 40% less chair time with All-on-4 digital workflow
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability1 record

Feature11 records

Partnerships

Four partnerships are on record, tiered core.

• Malo CliniccoreStrategic or Co-development Partner · 1 March 2026Straumann Group partnership with Malo Clinic announced March 2026 to advance full-arch rehabilitation solutions. Nobel Biocare is mentioned as a key player in the zygomatic and pterygoid implants market, though direct Malo Clinic partnership for Nobel Biocare is not explicitly stated in the sources.
• X-Nav Technologies (FastMap)coreTechnology or IntegrationX-Guide NXT with navigated photogrammetry FastMap integration in Nobel Biocare's All-on-4 digital workflow, enabling faster conversion-less full-arch workflows with passive-fit provisionals.
• 3ShapecoreTechnology or IntegrationNobelProcera solutions integrate with 3Shape dental scanner systems and software for prosthetic design and manufacturing workflows.
• exocadcoreTechnology or IntegrationNobelProcera open access partnership with exocad software enabling dental labs to design prosthetics compatible with Nobel Biocare systems.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Envista Holdings: Envista Holdings is Nobel Biocare's publicly traded parent company (NYSE: ENV), with additional dental brands including Nobel Biocare, KaVo Kerr, and Ormco. The broader portfolio overlaps in implants, orthodontics, and dental equipment, providing both support and potential cannibalization dynamics.
• Align Technology: Align Technology is a broad incumbent in digital dentistry through the Invisalign system and iTero scanners, with growing adjacency into implant workflows through integrated digital platforms. Overlaps with Nobel Biocare in the digital treatment planning and intraoral scanning ecosystem.

Others

• Henry Schein: Henry Schein is a major dental products distributor and parent of BioHorizons (a direct implant competitor). It serves as both a competitor (via BioHorizons) and a distribution channel partner for Nobel Biocare in select markets, making it an adjacent peer with mixed relationship dynamics.

Direct peers

• MIS Implants Technologies: MIS Implants (a Dentsply Sirona company) is a direct peer in dental implants with strong presence in value-tier markets. Competes with Nobel Biocare on price in cost-sensitive segments and offers similar surface treatments and implant system portfolios.
• Dentsply Sirona: Dentsply Sirona is a major direct peer with a comprehensive dental implants portfolio (Astra Tech, Ankylos, Xive) and broad dental equipment lines. The companies overlap directly in implant systems, CAD/CAM prosthetics (CEREC vs. NobelProcera), and digital treatment planning software.
• BioHorizons: BioHorizons (a Henry Schein company) is a direct peer in dental implants with Tapered Pro, Laser-Lok surface technology, and a strong presence in the value-to-premium tier. Overlaps directly with Nobel Biocare in implant systems sold to general dentists and specialists.
• Zimmer Biomet Dental: Zimmer Biomet's dental division is a direct peer in dental implants, particularly strong in North America with the T3 and Tapered Screw-Vent systems. Both compete in premium implant categories and regenerative solutions for the dental market.
• Straumann: Straumann Group is Nobel Biocare's closest direct competitor in premium dental implants and prosthetics, with comparable portfolio breadth across implant systems, CAD/CAM prosthetics, and digital workflows. Both companies lead the global dental implant market and compete head-to-head in surface technology, full-arch solutions, and digital dentistry software.
• Neodent: Neodent (a Straumann Group company) is a direct peer in dental implants focused on the value/premium tier with strong Latin American presence. Competes with Nobel Biocare across implant systems, prosthetics, and increasingly in digital workflows.

Emerging players

• 3Shape: 3Shape is a partner and emerging competitor in dental digital workflows, providing TRIOS intraoral scanners and CAD software that integrate with NobelProcera. As 3Shape expands its ecosystem, the relationship shifts from purely complementary to partly competitive in digital dentistry.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nobelbiocare
• YouTubeyoutube.com/nobelbiocare
• Facebookfacebook.com/NobelBiocare
• LinkedInlinkedin.com/company/nobel-biocare
• Instagraminstagram.com/nobelbiocare

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nobel Biocare